Wuhan Jingkangen Biomedical Technology

Wuhan Jingkangen Biomedical Technology is a specialized biotechnology company based in Wuhan, China, focusing on the fields of precision medicine and molecular diagnostics. Founded in 2017, the company leverages advanced high-throughput sequencing and single-cell analysis technologies to provide comprehensive clinical solutions, particularly in oncology and genetic disease screening. Their core offerings include diagnostic kit development, bioinformatics services, and customized antibody production for research and clinical applications. Operating out of the Wuhan East Lake High-tech Development Zone, the company serves as a key technical partner for hospitals and research institutions seeking to implement personalized healthcare strategies.